4min chapter

Speaking of Psychology cover image

Psychedelic therapy: Will it be a game changer for mental health treatment? with Albert Garcia-Romeu, PhD

Speaking of Psychology

CHAPTER

Do You Think That's a Good Idea?

Over 85% of participants in the clinical trials that to date have occurred using psilocybin and MDMA have been white. Culturally, I also think that there's a lot of mistrust of the medical institutions and biomedical research for a number of reasons. Less than 5% of people who are in trials of new FDA approved medications were coming from black African American Hispanic backgrounds. And so you're seeing, again, a very homogeneous population in many of these studies for any sort of medical research.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode